7,12-Dimethylbenz[a]anthracene

# N,N-Dimethylbenzylamine Commercial Market Dynamics Intelligence (October 12 – November 12, 2026)

---

## I. Recent Price Quotation Dynamics

| Date | Source | Quotation Status |
|------|--------|------------------|
| 2026-10-31 | SunSirs Benchmark Price | Released benchmark trading guidance price, including K adjustment coefficient and C premium/discount (logistics, brand, regional price differential) |
| 2026-11-06 | SunSirs Benchmark Price | Continued updating of the benchmark price model, reflecting the recent transaction settlement price range |
| 2026-11-09 | SunSirs Benchmark Price | Latest period quotation dynamics released, maintaining market trading activity |

> **Note:** SunSirs has consecutively released N,N-dimethylbenzylamine quotation dynamics three times within the past month (October 31, November 6, and November 9), indicating high market attention to this product, with price fluctuations within the monitoring cycle. Specific values require logging into the SunSirs platform to query the real-time benchmark price.

---

## II. Supply-Side Intelligence

**2.1 Production Capacity and Operating Rate**
- As of Q1 2026, the total domestic production capacity of N,N-dimethylbenzylamine reached **185,000 tons/year**.
- **Significant structural differentiation**: The proportion of advanced production capacity using continuous flow microreaction technology surged from 11.4% in 2022 to **38.7%**, with operating rates stable above **92%**.
- The average operating rate of traditional batch kettle processes is only **58%**, and a total of **38,000 tons/year** of backward production capacity has permanently exited the market due to loss of economic viability.

**2.2 Upstream Raw Material Changes**
- **12 out of the top 15** benzyl chloride production enterprises have completed tail gas resource recovery retrofitting, improving hydrogen chloride recovery rate to **96.5%**.
- Comprehensive energy consumption per ton decreased to **1.35 tons of standard coal**, a **28%** reduction compared to the early \"14th Five-Year Plan\" period.
- Suppliers with proprietary green process technology enjoy an **8%–12% premium** in long-term contract pricing, while the upstream raw material market concentration (CR5) has risen to **67%**.

**2.3 Technological Iteration**
- Continuous flow technology compresses reaction residence time to the second level, with target product selectivity breaking through **99.3%**.
- Raw material consumption per ton decreased by **18 kg**, and three-waste generation reduced by **42%**.
- Metal ion content in electronic-grade products is stably controlled below **5 ppb**, successfully entering the high-end supply chains of semiconductors and lithium batteries.

---

## III. Demand-Side Intelligence

**3.1 Downstream Application Structure**

| Application Area | Current Status and Trends |
|------------------|---------------------------|
| Dehydrogenation Catalysts | Core traditional application, stable demand |
| Preservatives | Continuous industrial-grade demand |
| Acid Neutralizers | Routine chemical industry support |
| New Energy Battery Electrolyte Additives | **Emerging high-growth scenario**, material cost reduced by 28.4% |
| Pharmaceutical Intermediates (Innovative Drug R&D) | Rising demand for high-purity customized products, review cycle shortened by 5.8 months |
| Special Surfactants | Accelerated domestic substitution, replacing 40% of European suppliers' share |

**3.2 Demand Upgrade Characteristics**
- The revenue share of customized business for leading enterprises has reached **38.7%**, with gross margins maintained in the **45%–62%** range and a customer churn rate of only **2.1%**.
- End users have significantly increased the weight of non-price factors such as supply chain resilience and ESG performance.

---

## IV. Market Competition Landscape

- Major global manufacturers include: Tokyo Chemical Industry, ATAMAN CHEMICALS, Reullei, Thermo Scientific Chemicals, Alfa Aesar, Shandong Minglang Chemical, Dalian Chemical, etc.
- Domestic leading enterprises are accelerating their transformation into \"molecular building block solution providers,\" leaping from single chemical supply to high-value-added services.
- Small and medium-sized production capacity is accelerating its exit, with market concentration continuously rising. The industry has entered a stage of comprehensive capability competition based on \"process greenness + product functionality + supply chain resilience.\"

---

## V. Policy and Compliance Environment

| Policy/Standard | Impact |
|-----------------|--------|
| Full life-cycle carbon footprint accounting under dual carbon goals | Forcing production model upgrades, high-carbon emission processes facing elimination |
| New Chemical Substances Environmental Management Registration System | Dynamic screening of market access, rising compliance costs |
| Special Rectification for Work Safety | Catalyzing the exit of small and medium-sized capacity and concentration of leading enterprises |
| Regional Chemical Park Certification Standards | Guiding optimization of industrial spatial layout |
| GHS 11th Revision and Cross-Border Data Flow Compliance | Reshaping the export paradigm, dual-compliant enterprises see export customs clearance time compressed to 4.5 days |

---

## VI. Analytical Judgment

**6.1 Short-term Judgment (Next 1–3 Months)**
- **Price Trend:** SunSirs' consecutive three-week release of quotation dynamics indicates active market trading. Affected by the cost transmission of upstream benzyl chloride green retrofitting and the exit of backward capacity, the price of industrial-grade N,N-dimethylbenzylamine is expected to **rise slightly or remain stable**, while high-end electronic-grade/pharmaceutical-grade products will maintain a **high premium** due to supply scarcity.
- **Supply-Demand Structure:** Advanced capacity operating rates are high but total volume is limited, while traditional capacity operates at low levels, resulting in a tight balance in overall supply.

**6.2 Medium-term Judgment (Next 3–12 Months)**
- The rearrangement of industrial ecological niches will accelerate, with the market share of continuous flow process enterprises further expanding.
- Demand increments in new energy and pharmaceutical fields are significant, but the bio-based synthesis route (whole-cell catalytic system with carbon footprint only 18% of fossil-based) is expected to reach a cost crossover point in **H2 2027 to H1 2028**. At that time, it may trigger approximately **20% demand transfer**, posing long-term pressure on the traditional fossil-based route.

**6.3 Long-term Judgment (Next 1–5 Years)**
- The industry profit distribution landscape will complete its ultimate reconstruction from \"tonnage-based pricing\" to a composite system of \"resilience premium + ESG assets + data trust + molecular value co-creation\" around **2028**.
- Verified listed companies have achieved a price-to-sales ratio of **6.5x**, significantly higher than the industry average of **2.2x**, reflecting high valuations by the capital market for enterprises with systemic innovation capabilities.

---

## VII. Forecast

| Dimension | Forecast |
|-----------|----------|
| Price Trend | Industrial-grade prices expected to remain stable to strong in the short term, with high-end grades maintaining high premiums; traditional route prices under pressure after the bio-based route cost crossover in 2027 |
| Capacity Changes | Continued exit of backward capacity, with advanced continuous flow capacity share expected to break 50% |
| Demand Growth | New energy + pharmaceutical fields driving CAGR higher than traditional fields, overall CAGR expected to remain in the mid-to-high single digits |
| Competitive Landscape | Accelerated concentration among leaders, CR5 expected to break 70%, SMEs lacking innovation capabilities face exit risks |
| Export Prospects | Enterprises completing the dual system of GHS + data compliance will gain a 6%–9% data trust premium, with a 94% repurchase rate in the European market |